107 related articles for article (PubMed ID: 26960452)
1. Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers.
Bag A; Jyala NS; Bag N
Indian J Cancer; 2015; 52(4):479-89. PubMed ID: 26960452
[TBL] [Abstract][Full Text] [Related]
2. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.
Wongpratate M; Ishida W; Phuthong S; Natphopsuk S; Ishida T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):243-248. PubMed ID: 31983191
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
5. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers.
Reszka E; Czekaj P; Adamska J; Wasowicz W
Clin Chem Lab Med; 2008; 46(8):1090-6. PubMed ID: 18590468
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
[TBL] [Abstract][Full Text] [Related]
7. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
8. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2005; 7(1):R12-8. PubMed ID: 15642161
[TBL] [Abstract][Full Text] [Related]
9. CYP1AI, glutathione S-transferase gene polymorphisms and risk of Polycythemia vera.
Naffa RG; Awidi AS; Yousef AM; Ismail SI
Cancer Epidemiol; 2012 Feb; 36(1):68-72. PubMed ID: 22018952
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.
Abo-Hashem EM; El-Emshaty WM; Farag Rel S; Zakaria S; Abd El-Aziz M; Ghonaim A
Biochem Genet; 2016 Oct; 54(5):696-713. PubMed ID: 27271262
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
13. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer.
Ye Z; Parry JM
Teratog Carcinog Mutagen; 2002; 22(5):385-92. PubMed ID: 12210502
[TBL] [Abstract][Full Text] [Related]
15. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
17. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
Dolzan V; Rudolf Z; Breskvar K
Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer.
Mota P; Moura DS; Vale MG; Coimbra H; Carvalho L; Regateiro F
Rev Port Pneumol; 2010; 16(1):89-98. PubMed ID: 20054510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
